Abstract
Helicobacter pylori stands as a significant risk factor for both peptic and stomach ulcers. Their resistance to the highly acidic host environment primarily stems from their capability to produce urease, an enzyme that rapidly converts urea into NH3 and CO2. These byproducts are crucial for the bacterium’s survival under such harsh conditions. Given the pivotal role of medicinal plants in treating various ailments with minimal side effects, there is an urgent need for a natural drug that can effectively eliminate H. pylori by inhibiting urease. Hence, the current study aims to identify the most potent urease inhibitor among the natural compounds found in Middle Eastern medicinal plants, taking into consideration factors such as optimal affinity, drug-like properties, pharmacokinetic characteristics, and thermodynamic attributes. In total, 5599 ligand conformers from 151 medicinal plants were subjected to docking against the urease’s active site. The top-ranking natural compounds, as determined by their high docking scores, were selected for further analysis. Among these compounds, D-glucosamine (PubChem code 439,213) exhibited the most interactions with the crucial amino acid residues in the urease’s active site. Furthermore, D-glucosamine demonstrated superior absorption, distribution, metabolism, excretion, and toxicity properties compared to other top-ranked candidates. Molecular dynamics simulations conducted over 100 nanoseconds revealed stable root mean square deviations and fluctuations of the protein upon complexation with D-glucosamine. Additionally, the radius of gyration and solvent-accessible surface area values for the D-glucosamine-urease complex were notably lower than those observed in other typical urease-inhibitor complexes. In conclusion, this study provides valuable insights into the potential development of D-glucosamine as a novel urease inhibitor. This promising compound holds the potential to serve as an effective drug for combating H. pylori infections in the near future.
Similar content being viewed by others
Data Availability
The docking structures and Excel spreadsheet are available upon request from the corresponding author.
References
Akada JK, Shirai M, Takeuchi H et al (2000) Identification of the urease operon in Helicobacter pylori and its control by mRNA decay in response to pH. Mol Microbiol 36:1071–1084
Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB (2021a) Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: a computational/simulation study. Comput Biol Med 141:105155. https://doi.org/10.1016/j.compbiomed.2021.105155
Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB (2021b) In silico Discovery of a new potent inhibitor for sterol 14-alpha demethylase as a promising antifungal drug against aspergillus fumigatus infection. Biointerface Res Appl Chem 12:5785–5796
Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB, Obayes DH (2022) Artecanin of Laurus nobilis is a novel inhibitor of SARS-CoV-2 main protease with highly desirable druglikeness. J Biomol Struct Dyn 41:2355–2367
Al-Shuhaib MBS, Alam S, Khan SA et al (2023a) Masoprocol: a promising candidate for targeting insulin resistance by inhibiting resistin with optimal druglikeness Potentials: an in silico approach. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2023.2254842
Al-Shuhaib MBS, Alam S, Khan SA et al (2023b) Hemagglutinin 3 and 8 can be the most efficient influenza subtypes for human host invasion; a comparative in silico approach. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2023.2280674
Asnaashari S, Dastmalchi S, Javadzadeh Y (2018) Gastroprotective effects of herbal medicines (roots). Int J Food Prop 21:902–920
Awaad AS, El-Meligy RM, Soliman GA (2013) Natural products in treatment of ulcerative colitis and peptic ulcer. J Saudi Chem Soc 17:101–124
Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF, Romero I (2014) Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol WJG 20:1450
Bansal Y, Silakari O (2012) The therapeutic journey of benzimidazoles: a review. Bioorg Med Chem 20:6208–6236
Bharatam PV (2021) Computer-aided drug design. Drug Discov Dev from Targets Mol to Med 1:137–210
Brenk R, Schipani A, James D et al (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem Chem Enabling Drug Discov 3:435–444
Chandrasekaran B, Abed SN, Al-Attraqchi O et al (2018) Computer-aided prediction of pharmacokinetic (ADMET) properties. Dosage form design parameters. Elsevier, New York, pp 731–755
Colzato LS, Ruiz MJ, van den Wildenberg WPM, Hommel B (2011) Khat use is associated with impaired working memory and cognitive flexibility. PLoS ONE 6:e20602
Cunha ES, Chen X, Sanz-Gaitero M et al (2021) Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 Å resolution. Nat Commun 12:1–8
El-Dien RTM, Maher SA, Abdelmohsen UR et al (2020) Antiulcer secondary metabolites from Elaeocarpus Grandis, family Elaeocarpaceae, supported by in silico studies. RSC Adv 10:34788–34799
Essmann U, Perera L, Berkowitz ML et al (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577–8593
Follmer C (2010) Ureases as a target for the treatment of gastric and urinary infections. J Clin Pathol 63:424–430
Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749
Galvin R, Cousins G, Boland F et al (2013) Prescribing patterns of glucosamine in an older population: a national cohort study. BMC Complement Altern Med 13:1–6
Ge R-G, Wang D-X, Hao M-C, Sun X-S (2013) Nickel trafficking system responsible for urease maturation in Helicobacter pylori. World J Gastroenterol WJG 19:8211
Ha N-C, Oh S-T, Sung JY et al (2001) Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol 8:505–509
Harrach MF, Drossel B (2014) Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J Chem Phys 140:174501
Harvey MJ, De Fabritiis G (2009) An implementation of the smooth particle mesh Ewald method on GPU hardware. J Chem Theory Comput 5:2371–2377
Hassan STS, Šudomová M (2017) The development of urease inhibitors: what opportunities exist for better treatment of Helicobacter pylori infection in children? Children 4:2
Khan S, Ullah H, Rahim F et al (2023) Synthesis, biological evaluation and molecular docking study of pyrimidine based thiazolidinone derivatives as potential anti-urease and anti-cancer agents. J Saudi Chem Soc 27:101688
Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36:996–1007
Krieger E, Nielsen JE, Spronk CAEM, Vriend G (2006) Fast empirical pKa prediction by Ewald summation. J Mol Graph Model 25:481–486
Kuna L, Jakab J, Smolic R et al (2019) Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. J Clin Med 8:179
Land H, Humble MS (2018) YASARA: a tool to obtain structural guidance in biocatalytic investigations. Protein Engineering. Springer, Berlin, pp 43–67
Liang B, Yuan Y, Peng X-J et al (2022) Current and future perspectives for Helicobacter pylori treatment and management: from antibiotics to probiotics. Front Cell Infect Microbiol 12:1740
Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337–341
Loughlin MF (2003) Novel therapeutic targets in Helicobacter pylori. Expert Opin Ther Targets 7:725–735
Minkara MS, Ucisik MN, Weaver MN, Merz KM Jr (2014) Molecular dynamics study of Helicobacter pylori urease. J Chem Theory Comput 10:1852–1862
Mobley HLT, Mendz GL, Hazell SL (2001) Helicobacter pylori: physiology and genetics. Washington (DC), ASM Press
Noe MC, Peakman M-C (2017) Drug discovery technologies: Current and future trends. In: S. Chackalamannil, D. Rotella, S.E. Ward (eds) Comprehensive Medicinal Chemistry III, Elsevier, Oxford, pp. 1–32
Repetto MG, Llesuy SF (2002) Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Brazilian J Med Biol Res 35:523–534
Roszczenko-Jasińska P, Wojtyś MI, Jagusztyn-Krynicka EK et al (2018) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Future Microbiol 3:435–444
Roszczenko-Jasińska P, Wojtyś MI, Jagusztyn-Krynicka EK (2020) Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets. Appl Microbiol Biotechnol 104:9891–9905
Santhosh S, Mathew PT (2008) Preparation and properties of glucosamine and carboxymethylchitin from shrimp shell. J Appl Polym Sci 107:280–285
Santhosh S, Anandan R, Sini TK et al (2005) Biochemical studies on the antiulcer effect of glucosamine on antioxidant defense status in experimentally induced peptic ulcer in rats. J Clin Biochem Nutr 37:61–66
Takeuchi H, Trang VT, Morimoto N et al (2014) Natural products and food components with anti-helicobacter pylori activities. World J Gastroenterol WJG 20:8971
Tarsia C, Danielli A, Florini F et al (2018) Targeting Helicobacter pylori urease activity and maturation: In-cell high-throughput approach for drug discovery. Biochim Biophys Acta (BBA)-General Subj 1862:2245–2253
Uprety B, Chandran R, Arderne C, Abrahamse H (2022) Anticancer activity of urease mimetic cobalt (III) complexes on A549-lung cancer cells: targeting the acidic microenvironment. Pharmaceutics 14:211
Valenzuela-Valderrama M, Cerda-Opazo P, Backert S et al (2019) The helicobacter pylori urease virulence factor is required for the induction of hypoxia-induced factor-1α in gastric cells. Cancers (Basel) 11:799
Zhang H, Jiang Q, Gong G et al (2023) Alpinetin: anti-human gastric cancer potential and urease inhibition activity in vitro. Arch Med Sci AMS 19:1479
Funding
This study did not receive any support from any institution or supporting agency.
Author information
Authors and Affiliations
Contributions
MBSA: Conceptualization, Methodology. Software, Writing–Original draft preparation. HOH; Software, Data curation, JMBA; Data curation, Reviewing and Editing. All authors approved the final draft of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have any financial or personal relationships that could inappropriately influence or bias the content of the paper.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Al-Shuhaib, M.B.S., Hashim, H.O. & Al-Shuhaib, J.M.B. D-Glucosamine is a Potential Urease Inhibitor from Middle Eastern Medicinal Plants for Combatting Helicobacter Pylori Infections; a Molecular Docking and Simulation Approach. Biochem Genet (2024). https://doi.org/10.1007/s10528-024-10709-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-024-10709-5